Albiomin 20% (200 g/l), solution for infusion Malta - Inggeris - Medicines Authority

albiomin 20% (200 g/l), solution for infusion

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - albumin, human - solution for infusion - albumin, human 20 % (w/v) - blood substitutes and perfusion solutions

PLASBUMIN (albumin- human solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

plasbumin (albumin- human solution

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - emergency treatment of hypovolemic shock plasbumin-20 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (plasbumin® -5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual; i.e., about 2 g per kg body weight in the absence of active bleeding. although plasbumin-5 is to be preferred for the usual volume deficits, plasbumin-20 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic flu

ALBUKED (albumin- human solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

albuked (albumin- human solution

kedrion biopharma, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - emergency treatment of hypovolemic shock albuked 25 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (albuked™ 5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual, i.e., about 2 g per kg body weight in the absence of active bleeding. although albuked 5 is to be preferred for the usual volume deficits, albuked 25 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic fluid from a

Zenalb 20, 200g/l Solution for Infusion Malta - Inggeris - Medicines Authority

zenalb 20, 200g/l solution for infusion

bpl bioproducts laboratory gmbh dornhofstraße 34, 63263 neu-isenburg,, germany - albumin, human - solution for infusion - albumin, human 20 % (w/v) - blood substitutes and perfusion solutions

Albumex 20 New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

albumex 20

csl behring (nz) ltd - albumin 200 g/l (albumin ex nz) - solution for infusion - 20% w/v - active: albumin 200 g/l (albumin ex nz) excipient: octanoate ions sodium water for injection - hypoproteinaemia in the acutely ill patient; albumex® 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy.

UMAN ALBUMIN Israel - Inggeris - Ministry of Health

uman albumin

kamada ltd, israel - albumin human - solution for infusion - albumin human 200 mg/ml - albumin - albumin - for restoration and maintenance of circulating blood volume where volume deficiency has been demontrated and use of a colloid such as albumin is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient based on official recommendations.

ALBUNATE 20 Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

albunate 20 human albumin 200 g/l (20% w/v) 50 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 10 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; sodium chloride; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUNATE 20 Human Albumin 200 g/L (20% w/v) 100 mL solution for intravenous infusion vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

albunate 20 human albumin 200 g/l (20% w/v) 100 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 20 g - injection, intravenous infusion - excipient ingredients: sodium octanoate; water for injections; sodium chloride; sodium acetyltryptophanate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

Human Albumin Biotest 20% solution for infusion 50ml vials United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

human albumin biotest 20% solution for infusion 50ml vials

biotest (uk - albumin solution human - solution for infusion - 200mg/1ml

Human Albumin Biotest 20% solution for infusion 100ml vials United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

human albumin biotest 20% solution for infusion 100ml vials

biotest (uk - albumin solution human - solution for infusion - 200mg/1ml